Clinical Trial Update: A Study of Dryvax Vaccine Against Smallpox in Previously Unvaccinated Adults [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 clinical trial evaluating the Dryvax live vaccinia vaccine for protection against smallpox in adults who had n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smallpox

Drugs mentioned

• Dryvax vaccine (Vaccinia virus vaccine (live))

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Smallpox | Phase 2 | Status: COMPLETED